Recent Progress in the Design and Application of Supramolecular Peptide Hydrogels in Cancer Therapy

Supramolecular peptide hydrogel (SPH) is a class of biomaterials self‐assembled from peptide‐based gelators through non‐covalent interactions. Among many of its biomedical applications, the potential of SPH in cancer therapy has been vastly explored in the past decade, taking advantage of its good b...

Full description

Saved in:

Bibliographic Details
Published in:	Advanced healthcare materials 2021-01, Vol.10 (1), p.e2001239-n/a
Main Authors:	Cai, Ying, Zheng, Chao, Xiong, Fengqin, Ran, Wei, Zhai, Yihui, Zhu, Helen H., Wang, Hao, Li, Yaping, Zhang, Pengcheng
Format:	Article
Language:	eng
Subjects:	Biocompatibility Biocompatible Materials Biological properties Biomaterials Biomedical materials Cancer Cancer therapies Chemical compounds Drugs Hydrogels Injectability local therapy Neoplasms - drug therapy Peptides Physicochemical properties Prodrugs supramolecular self‐assembly Therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Supramolecular peptide hydrogel (SPH) is a class of biomaterials self‐assembled from peptide‐based gelators through non‐covalent interactions. Among many of its biomedical applications, the potential of SPH in cancer therapy has been vastly explored in the past decade, taking advantage of its good biocompatibility, multifunctionality, and injectability. SPHs can exert localized cancer therapy and induce systemic anticancer immunity to prevent tumor recurrence, depending on the design of SPH. This review first gives a brief introduction to SPH and then outlines the major types of peptide‐based gelators that have been developed so far. The methodologies to tune the physicochemical properties and biological activities are summarized. The recent advances of SPH in cancer therapy as carriers, prodrugs, or drugs are highlighted. Finally, the clinical translation potential and main challenges in this field are also discussed. This progress report gives a brief introduction to supramolecular peptide hydrogels (SPHs) and summarizes strategies to tune the physicochemical and biological properties of the SPHs. A focus is given to the recent advances in SPH‐based cancer therapy, and the challenges in this field are discussed.
ISSN:	2192-2640 2192-2659